TY  - CHAP
M1  - Book, Section
TI  - Diabetic Peripheral Arterial Disease
A1  - Scanlon, James M.
A1  - Macsata, Robyn A.
A1  - Neville, Richard F.
A1  - Sidawy, Anton N.
A2  - Dieter, Robert S.
A2  - Dieter, Raymond A.
A2  - Dieter, Raymond A.
Y1  - 2009
N1  - 
T2  - Peripheral Arterial Disease
AB  - Diabetes  mellitus  is  among  the  leading  causes  of  mortality  and  major  morbidity  in  the  United  States.  It  continues  to  plague  society  with  an  additional  800  000  new  cases  diagnosed  each  year.1  Consequently,  the  cost  of  treating  the  associated  complications  such  as  cardiovascular  death,  end-stage  renal  failure,  and  major  amputations  has  created  a  growing  economic  burden  on  U.S.  health  care  systems.  Fifty  percent  of  diabetics  will  be  affected  by  a  manifestation  of  diabetic  foot  (neuropathy,  ischemia,  or  infection)  and  15%  of  diabetics  will  experience  a  foot  ulcer  in  their  lifetime.2,3  Diabetic  foot  problems  are  among  the  leading  causes  of  hospitalization  for  diabetics;  the  cost  of  caring  for  diabetic  foot  ulcers  is  estimated  as  high  as  $13  billion  annually,  a  figure  that  is  approximately  27%  of  the  total  cost  of  diabetes  care.4  Its  seriousness  cannot  be  overstated;  20%  of  those  affected  with  a  foot  ulcer  will  progress  to  an  amputation,  a  lower  extremity  amputation  rate  of  4.1  per  1000  diabetics  per  year.1,5  This  confers  an  amputation  relative  risk  40  times  greater  for  diabetics  and  a  reamputation  rate  of  more  than  60%  at  5  years.3,6  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1127169221
ER  -